AusPAR: Risankizumab

Australian Public Assessment Report

AusPAR

AusPAR: Risankizumab [PDF, 1.37 MB]

AusPAR: Risankizumab [Word, 2.2 MB]

Attachment: Product Information for Risankizumab [PDF, 232.48 KB]

Attachment: Product Information for Risankizumab [Word, 183.18 KB]

Device/Product Name

Skyrizi

Active ingredients

Risankizumab

AusPAR Date

22 January 2020

Published

12 February 2020

Submission Number

PM-2018-01889-1-1

Submission Type

New biological entity

Decision

Approved